Telesis Bio Reports Second Quarter and First Half 2024 Financial Results
August 07, 2024 16:05 ET
|
Telesis Bio
SAN DIEGO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced,...
Telesis Bio Reports First Quarter 2024 Financial Results
May 09, 2024 16:05 ET
|
Telesis Bio
Telesis Bio Reports First Quarter 2024 Financial Results
Telesis Bio Announces Reverse Stock Split
May 06, 2024 16:05 ET
|
Telesis Bio
Telesis Bio Announces Reverse Stock Split
Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership
April 18, 2024 09:00 ET
|
Telesis Bio
Telesis Bio Inc. announces strategic focus on mRNA solutions and announces new leadership
Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
March 28, 2024 16:05 ET
|
Telesis Bio
SAN DIEGO, March 28, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced,...
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
February 26, 2024 09:15 ET
|
Telesis Bio
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
Telesis Bio Reports Third Quarter 2023 Financial Results
November 13, 2023 16:22 ET
|
Telesis Bio
SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today reported financial results for the third quarter...
Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023
November 07, 2023 09:00 ET
|
Telesis Bio
SAN DIEGO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its third quarter 2023...
Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA
November 03, 2023 12:00 ET
|
Telesis Bio
SAN DIEGO, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp®...
Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS
September 28, 2023 15:48 ET
|
Telesis Bio
SAN DIEGO, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp®...